SynthesisGenes2026

Tumor Genomic Biomarkers as Prognostic Modifiers of Outcomes Following CD19 CAR T-Cell Therapy in Aggressive Large B-Cell Lymphoma: A Systematic Review and Exploratory Meta-Analysis.

Jingke Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.